Skip to content

: Renal Cell Carcinoma Fibrosis Stroma Multianalyte Tissue Test

Published: August 9, 2026Updated: August 16, 2026

: This test examines tissue from a kidney tumor for markers related to the fibrous stroma—the supportive connective tissue surrounding the cancer—using a multianalyte tissue analysis.

Quick summary

[": It is a specialized tumor-tissue test that looks at multiple stromal markers in renal cell carcinoma to help characterize the tumor environment."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
105591-2
Short code
RCC fibro stroma mult anl Tiss
Synonyms
RCC fibro stroma mult anl Tiss
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

: What This Test Measures

: The test analyzes a sample of tumor tissue for several substances (analytes) associated with the fibrous, scar-like stroma that can form around renal cell carcinoma. By measuring more than one marker at once, it aims to give a broader picture of the tissue environment than a single measurement would.

: Why Stroma Matters in Kidney Cancer

: The stroma is the supportive tissue framework around tumor cells. In some cancers, a dense fibrous stroma can influence how the tumor grows and spreads, and researchers study stromal features to better understand tumor behavior and potential prognosis.

: How the Sample Is Collected

: This is a tissue-based test, so it requires a tissue specimen—typically obtained during a biopsy or surgery to remove part of or all of a kidney tumor. The laboratory then processes and analyzes that tissue.

: What the Results Mean

: Results describe the presence or levels of the measured stromal markers in the tissue sample. Because this is a specialized, non-routine panel, interpretation depends on the specific markers reported and should be discussed with your care team in the context of your diagnosis.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

: RCC Fibrotic Stroma Tissue Panel

Frequently asked questions

: Is this a blood test?
: No. It is a tissue-based test that requires a sample of tumor tissue, usually collected during a biopsy or surgery.
: Can I get this test at a routine lab?
: Unlikely. This type of specialized multianalyte stromal panel is generally offered in research or specialized pathology settings, not standard community laboratories.
: Does a result tell me my prognosis?
: Not by itself. Stromal findings may add information, but prognosis is judged from the whole picture—tumor type and stage, pathology, imaging, and your overall health—so discuss results with your care team.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy